Verition Fund Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.7M Buy
294,345
+233,160
+381% +$4.59M 0.03% 703
2026
Q2
$1.57M Sell
61,185
-293,674
-83% -$6.91M 0.01% 1221
2026
Q1
$5.31M Buy
354,859
+90,712
+34% +$1.55M 0.03% 552
2025
Q4
$3.85M Buy
264,147
+228,946
+650% +$3.99M 0.02% 1073
2025
Q3
$632K Sell
35,201
-548,737
-94% -$8.05M ﹤0.01% 2880
2025
Q2
$10M Buy
+583,938
New +$5.84M 0.04% 530
2025
Q1
– Sell
-194,661
Closed -$2.73M – 3378
2024
Q4
$2.73M Buy
194,661
+102,104
+110% +$1.51M 0.01% 1345
2024
Q3
$1.1M Buy
92,557
+12,925
+16% +$134K 0.01% 1825
2024
Q2
$741K Buy
79,632
+48,441
+155% +$247K ﹤0.01% 1842
2024
Q1
$110K Buy
+31,191
New +$108K ﹤0.01% 2570

Other funds holding CORZ

Verition Fund Management's CORZ Position: Q3 2026 in Review

Verition Fund Management increased its Core Scientific (CORZ) stake by 381% in Q3 2026, buying an estimated $4.59M and bringing the position to 294,345 shares worth $4.7M. The position accounts for 0.03% of the portfolio, ranked #703.

Verition Fund Management first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $10M in Q2 2025. 413 funds tracked by Wall St. Rank hold CORZ as of Q3 2026.

  • Verition Fund Management held 294,345 shares of Core Scientific worth $4.7M as of Q3 2026.
  • Verition Fund Management bought 233,160 Core Scientific shares in Q3 2026, an estimated $4.59M.
  • Core Scientific made up 0.03% of Verition Fund Management's portfolio in Q3 2026, its #703 holding.
  • Verition Fund Management first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • Verition Fund Management's Core Scientific position peaked at $10M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q3 2026.

Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.